Results 1 to 10 of about 139,496 (193)

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer [PDF]

BMC Cancer
Background The clinical characteristics of immune checkpoint inhibitors (ICIs)-related myocarditis in lung cancer remains uncertain. The purpose of this study was to evaluate the incidence, clinical characteristics, risk factors, and prognosis of ...
Wenli Cao, Sen Han, Panpan Zhang, Lan Mi, Yang Wang, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Xiaoling Chen, Xiangjuan Ma, Guangming Tian, Jindi Han, Di Wu, Jieran Long, Ziran Zhang, Qianyun Hao, Jian Fang, Kai Wang   +18 more
doaj   +2 more sources

Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study

BMJ Medicine, 2023
Objective To investigate the clinical outcomes of myocarditis associated with mRNA vaccines against the SARS-CoV-2 virus compared with other types of myocarditis.Design Population based cohort study.Setting Nationwide register data from four Nordic ...
Øystein Karlstad, Lars Køber, Tommi Härkänen, Anders Husby, Jørgen Vinsløv Hansen, Anders Hviid, Rickard Ljung, Jesper Dahl, Hanne Løvdal Gulseth, Tiina Heliö, Nina Gunnes, Petteri Hovi, Nicklas Pihlström   +12 more
doaj   +1 more source

Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Although rare, classic viral myocarditis in the pediatric population is a disease that carries significant morbidity and mortality. Since 2020, myocarditis has been a common component of multisystem inflammatory syndrome in children (MIS‐C ...
Trisha Patel, Michael Kelleman, Zachary West, Andrew Peter, Matthew Dove, Arene Butto, Matthew E. Oster   +6 more
doaj   +1 more source

Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue

Frontiers in Cellular and Infection Microbiology, 2023
Numerous studies have demonstrated that gut microbiota plays an important role in the development and treatment of different cardiovascular diseases, including hypertension, heart failure, myocardial infarction, arrhythmia, and atherosclerosis ...
Jingyue Wang, Jingyue Wang, Xianfeng Zhang, Xinyu Yang, Xinyu Yang, Hang Yu, Mengmeng Bu, Jie Fu, Zhengwei Zhang, Hui Xu, Jiachun Hu, Jinyue Lu, Haojian Zhang, Zhao Zhai, Wei Yang, Xiaodan Wu, Yan Wang, Qian Tong   +17 more
doaj   +1 more source

COVID myocarditis: a review of the literature

Monaldi Archives for Chest Disease, 2023
Myocarditis is a potentially fatal complication of coronavirus disease 2019 (COVID‐19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. COVID‐19 myocarditis appears to have distinct inflammatory characteristics
Angelica Cersosimo, Mattia Di Pasquale, Gianmarco Arabia, Marco Metra, Enrico Vizzardi   +4 more
doaj   +1 more source

Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study

Frontiers in Immunology, 2022
Background and ObjectiveImmune checkpoint inhibitor (ICI)-associated myocarditis is a fatal immune-related adverse events (irAEs), which is prone to affecting multiple organ systems.
Xiaohong Xie, Liqiang Wang, Liqiang Wang, Yingqing Li, Yan Xu, Jianhui Wu, Xinqing Lin, Wen Lin, Qicong Mai, Zhanhong Chen, Jiexia Zhang, Zhanhong Xie, Yinyin Qin, Ming Liu, Mingjun Lu, Bihui Luo, Chengzhi Zhou   +16 more
doaj   +1 more source

COVID-19 and myocarditis: a review of literature

The Egyptian Heart Journal, 2022
Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus.
Mohammed Ali, Haaris A. Shiwani, Mohammed Y. Elfaki, Moaz Hamid, Rebabonye Pharithi, Rene Kamgang, Christian BinounA Egom, Jean Louis Essame Oyono, Emmanuel Eroume-A Egom   +8 more
doaj   +1 more source

A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support. [PDF]

, 2020
Giant cell myocarditis is a rare but often devastating diagnosis. Advances in cardiac imaging and mechanical circulatory support have led to earlier and more frequent diagnoses and successful management. This disease state has wide variation in acuity of
Dunn, Steven P, Fallon, Julianne M, Kennedy, Jamie LW, Parker, Alex M   +3 more
core   +1 more source

Immune mechanisms of group B coxsackievirus induced viral myocarditis

Virulence, 2023
Viral myocarditis is known to be a primary cause of dilated cardiomyopathy (DCM) that can lead to heart failure and sudden cardiac death and is invariably caused by myocardial viral infection following active inflammatory destruction of the myocardium ...
Yue Zhang, Xiaobin Zhou, Shuyi Chen, Xinchen Sun, Chenglin Zhou   +4 more
doaj   +1 more source

Myocarditis, disseminated infection, and early viral persistence following experimental coxsackievirus B infection of cynomolgus monkeys. [PDF]

, 2013
Coxsackievirus B (CVB) infection is a common cause of acute viral myocarditis. The clinical presentation of myocarditis caused by this enterovirus is highly variable, ranging from mildly symptoms to complete hemodynamic collapse.
Blanchard, James, Bohm, Rudolf, Cammock, Cheryl E, Halnon, Nancy J, Krogstad, Paul A, Lai, Chi, Miller, Christopher J, Skoczylas, Jill   +7 more
core   +6 more sources